766 studies found for:    Diabetic Neuropathy
Show Display Options
Rank Status Study
21 Unknown  Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
Condition: Diabetic Peripheral Neuropathy
Intervention: Other: Skin biopsy
22 Completed
Has Results
Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy
Conditions: Pain;   Diabetic Neuropathy
Interventions: Drug: AZD2066;   Drug: Placebo
23 Completed
Has Results
A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Drug: lacosamide
24 Completed Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy
Condition: Diabetic Neuropathies
Intervention: Drug: SPM 927
25 Completed Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy
Condition: Diabetic Neuropathy, Painful
Interventions: Device: Frequency Modulated Neural Stimulation (FREMS) (Aptiva);   Device: sham treatment (Aptiva)
26 Completed An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Intervention: Drug: SPM927/Lacosamide
27 Completed Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Genetic: hVEGF-A
28 Completed A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Intervention: Drug: SPM 929
29 Completed Cognitive Behavioral Therapy for Painful Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Behavioral: cognitive behavioral therapy;   Other: standard medical care
30 Completed Role of Indicator Test (Neuropad) in Detecting Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention:
31 Not yet recruiting The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy
Conditions: Diabetic Neuropathies;   Complex Regional Pain Syndrome Type II;   Resistant Peripheral Neuropathic Pain;   Chemotherapy Induced Pain Neuropathy
Intervention: Device: TDCS/sham procedure on five consecutive days
32 Completed Safety and Efficacy Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Conditions: Painful Diabetic Neuropathy;   Diabetic Neuropathy;   Neuropathy
Interventions: Drug: Clonidine Gel 0.1%;   Drug: Placebo
33 Active, not recruiting Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Behavioral: Exercise
34 Unknown  The Evaluation of Safety and Efficacy of JWHGWT on Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Drug: placebo;   Drug: JWHGWT
35 Completed
Has Results
A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Drug: Tramadol hydrochloride/ Acetaminophen;   Drug: Gabapentin
36 Completed VEGF Gene Transfer for Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Biological: VEGF
37 Completed A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy
Conditions: Painful Diabetic Neuropathy;   Diabetes
Intervention: Drug: clonidine hydrochloride topical gel, 0.1%
38 Completed Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy
Condition: Diabetic Neuropathies
Intervention: Drug: BK-C-0701
39 Completed A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Interventions: Drug: SPM927/Lacosamide;   Other: Placebo
40 Withdrawn Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy
Condition: Diabetic Neuropathies
Interventions: Drug: EMA401 600mg;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years